In 2023, the Current Health Expenditure Per Capita in South Africa stood at $570. Examining the data for the subsequent years, we observe a steady increase: $574.7 in 2024, $579.53 in 2025, $583.95 in 2026, $588 in 2027, and $591.72 in 2028.
The year-on-year variation indicates a consistent upward trend, suggesting a gradual increase in health expenditure per capita over this period. Specifically, from 2024 to 2025, the growth rate is approximately 0.84%, from 2025 to 2026 it is about 0.76%, from 2026 to 2027 it is roughly 0.69%, and from 2027 to 2028, the growth rate is around 0.63%.
The compound annual growth rate (CAGR) for the period from 2024 to 2028 is approximately 0.73%, encompassing an average annual increase in health expenditure per capita, highlighting a consistent rise in healthcare spending over time.
Future trends to watch for include the impact of inflation on healthcare costs, the influence of technological advancements in healthcare delivery, and the potential changes in government healthcare policies which could significantly affect spending patterns and the overall financial health of the populace.
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...